FDA Updates Rules on Who Can Donate Their Body Parts
Published Date: 1/7/2025
Notice
Summary
The FDA just dropped a draft guide to help decide who can donate human cells and tissues safely. This update affects doctors, tissue banks, and anyone involved in donations, aiming to keep diseases from spreading. You’ve got until February 6, 2025, to share your thoughts before the final rules roll out—no big costs yet, just smarter safety checks!
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Draft donor-eligibility guidance released
The FDA published a draft guidance titled "Recommendations for Determining Eligibility of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)" and is accepting comments through February 6, 2025. The draft updates existing recommendations to assist establishments that make donor eligibility determinations, including revised exceptions, clarifications to the donor medical history interview, and considerations about specimens for donor testing.
Planned pathogen-specific guidances
FDA intends to issue separate additional guidances addressing reducing transmission risk for specific agents including HIV, hepatitis B and C, Mycobacterium tuberculosis, sepsis, transmissible spongiform encephalopathies, cytomegalovirus, Chlamydia trachomatis, Neisseria gonorrhoeae, human T-lymphotropic virus, Treponema pallidum (syphilis), vaccinia virus, West Nile virus, and xenotransplantation. These pathogen-specific recommendations will be issued in addition to the general donor-eligibility guidance.
Zika guidance withdrawn—ZIKV not relevant
FDA has withdrawn the 2018 guidance ‘‘Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products’’ and states that Zika virus (ZIKV) is no longer considered a relevant communicable disease agent for potential HCT/P donors. The withdrawal and determination are explicitly noted in the draft guidance announcement.
FDA will publish comprehensive donor lists
When finalized, FDA intends to collate the general and specific guidances and publish comprehensive lists on its website of: conditions and behaviors that increase donor communicable-disease risk; examples of clinical and physical evidence of disease or high-risk behavior; disease agents for which all donors must be tested; and the types of tests FDA currently considers adequate to meet 21 CFR 1271.80(c).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-20724, Notice of Intent To Prepare a Supplemental Environmental Impact Statement for the Sentinel Deployment and Minuteman III Decommissioning and Disposal
The Air Force is updating its plan to replace old Minuteman III missiles with new Sentinel missiles across five states, including Wyoming, Montana, and North Dakota. They’re checking how these changes might affect the environment and want your thoughts during a 30-day comment period starting now. This update could impact local lands and communities, with careful reviews to keep things safe and smart.
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20708, Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX Rule 15.110(a) and (c) To Amend the IEX Equities Fee Schedule
IEX is shaking up its fee schedule starting November 1, 2026, by tweaking who gets rebates for adding displayed liquidity and changing rebate amounts. This affects IEX members who trade stocks, giving them new ways to save or earn more on fees. The changes kick in right away after filing, so traders should get ready to adjust their strategies and cash flow.
2026-20710, Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX Rule 15.110(a) and (c) To Modify the Required Criteria To Qualify for the Reduced Incremental Fee
Investors Exchange (IEX) is changing the rules for who can get a discount on certain trading fees. Starting November 1, 2026, members will need to meet new criteria to qualify for the reduced incremental fee, which could save or cost them money depending on their trading activity. This change affects all IEX members and kicks in right away to keep things fair and clear.
2026-20779, Passenger Vehicle and Light Truck Tires From Thailand: Preliminary Results and Rescission, in Part, of Antidumping Duty Administrative Review; 2024-2025
The U.S. Department of Commerce found that tires from Thailand were sold in the U.S. for less than their normal price between July 2024 and June 2025. This means some importers might have to pay extra duties to keep things fair. The review process had some delays due to government shutdowns, but now the preliminary results are out and open for comments.
2026-20763, National Environmental Policy Act Implementing Procedures: Wintertime Oil and Gas Exploration in the National Petroleum Reserve in Alaska Categorical Exclusion
Starting October 9, 2026, the Department of the Interior is making it easier and faster to approve wintertime oil and gas exploration in Alaska’s National Petroleum Reserve by adding a special rule that skips some usual paperwork. This change mainly affects energy companies working in the area and aims to speed up projects while still protecting the environment. No new costs are expected, but the process will be smoother and quicker.
Previous / Next Documents
Previous: 2024-31523, Draft Guidances Relating to Recommendations To Reduce the Risk of Transmission of Relevant Communicable Disease Agents and Diseases by Human Cells, Tissues, and Cellular and Tissue-Based Products; Draft Guidances for Industry; Availability
The FDA just shared new draft guides to help companies that handle human cells and tissues keep dangerous viruses like Hepatitis B, Hepatitis C, and HIV from spreading. These updates make it clearer how to check donors and keep everyone safe. If you work in this field, you’ve got until February 6, 2025, to share your thoughts before the rules get finalized—so get ready to review and maybe adjust your processes!
Next: 2024-31525, Food and Drug Administration Animal Food Ingredient Consultation; Guidance for Industry; Availability
The FDA just rolled out a new way for companies making animal food ingredients to check in with them, called the Animal Food Ingredient Consultation (AFIC). This replaces the old process with AAFCO, which ended in October 2024, and helps spot safety issues early while keeping the public in the loop. If you’re in the animal feed business, this means new steps to follow, but no extra fees—just smarter safety checks starting now!